BIOBANKING: END-USERS - A GLOBAL MARKET WATCH, 2009-2015

Global Market Watch
With a CAGR of 7.9%, global market value for biorepositories market is anticipated to be worth US$23.9 billion by 2015. On a global scale, North America accounts for more than 30% of the market. While US accounts for the highest share of the global market value on a country basis, India and China surpasses the US in terms of growth rate anticipated in the near future and leads the world. Pharmaceuticals account for the largest share of the entire market, driving a CAGR of 8.5% during the analysis period 2009-2015. Biotechnology sees as the fastest growing end-user with a forecast of US$4.9 billion by 2015, with a CAGR of 9.2%. Personal Care and Food and Beverages segments indicate a CAGR ofapproximate 8% during the period while Petrochemicals are expected to grow with a CAGR of 7%.

Report Focus:
The ‘Biobanking: End-Users - A Global Market Watch, 2009-2015’ reviews the latest trends in biobanking sector with a perceptive to disclose the near-future growth prospects in. An in-depth analysis across the geographic regions provides strategic business intelligence for life science and as well as healthcare sector investments. The study offers profitable investment strategies for R&D organizations, pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations. The report primarily focuses on:
• Latest Market Trends
• Region-wise Demand Factor
• Key Growth Areas
• Market Sizes
• Key Competitors Edge
• Investment Strategies

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases and published research reports are also used for estimates. Estimates have incorporated recessionary impact on the industry. The analysis is based on desk research and interviews with biobank researchers and law/ethics specialists, as well as on data collected through the survey, and discussions with experts.
The report delivers a microscopic view of regional market values. The major end-userareas discussed in the report are:
BY END- USE MARKETS
• Pharmaceuticals (Biomarkers, Drug Discovery, Therapeutics, Clinical Trials and R&D)
• Biotechnology
• Personal Care
• Food and Beverage
• Petrochemicals &
• Other (Contract Services, Process Chemicals and Others)

The report focuses on the current market trends, estimates and forecasts for the period 2009-2015. More than 1000 in biorepositories market and 120 leading market players that project improved market activities in the near future are profiled. The report consists of 134 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed which gives a deep insight into the growth perspectives of the market.
The region-wise distribution of the market consists of North America (USA, Canada and Mexico); Europe (Belgium, Denmark, France, Germany, Greece, Italy, Spain, Sweden, United Kingdom and Rest of Europe); Asia-Pacific (Australia, China, India, Japan, South Korea and Rest of Asia-Pacific) and Rest of the World (Argentina, Brazil, Columbia, Middle East, South Africa and Rest of Rest of World). Incorporating the recession impacts on the industry, the market growth rate in the major economies such as the U.S., Japan and China along with the other emerging countries are estimated individually for the upcoming years. Anticipating a protracted economic recovery towards to 2011 and based on the CAGR estimates and growth potential, we have forecasted the market size figures for the next five years.
The report also covers major industry participants with details of their services, projects and financial status. Below are few among the 120Biorepositories/Biobankingcompany profiles in our report:-
THERMO FISHER SCIENTIFIC
SANYO BIOMEDICAL
NEW BRUNSWICK SCIENTIFIC
LABVANTAGE SOLUTIONS, INC.
LABWARE, INC.
STARLIMS CORPORATION
GENVAULT CORPORATION
QIAGEN
TECAN
BECKMAN COULTER
ATGC LABS
DATAWORKS DEVELOPMENT, INC.
BIOSTORAGE TECHNOLOGIES, INC.
PACIFIC BIO-MATERIAL MANAGEMENT, INC.
PROMEDDX, LLC
SEQWRIGHT DNA TECHNOLOGY SERVICES
STEELGATE, INC.
WHEATON
VIVAKOR, INC
NOVARE BIOLOGISTICS
AUTOGEN, INC.
CALIPER LIFE SCIENCES, INC.
HAMILTON STORAGE &
AND MANY MORE…………

Global Genomics Industry

TABLE OF CONTENTS

I. REPORT FOCUS
A. INTRODUCTION

1. BIOREPOSITORIES
BIOREPOSITORY OPERATIONS
BIOSPECIMEN SECURITY AND STORAGE

WORLDWIDE BIOREPOSITORIES
VOUCHER SPECIMENS LINKED BY SEQUENCE DATA RECORDS
INSTITUTIONAL/NON-INSTITUTIONAL ACRONYMS AND COLLECTION CODES
CONSERVATION OF BIOREPOSITORIES AND ASSOCIATED DATABASES
BIOREPOSITORIES FROM RECENT CANCER PREVENTION TRIALS
DNA BIOBANKS WITH AUTOMATED DNA EXTRACTION AND NORMALIZATION
DNA ELUTION AND NORMALIZATION

2. BIOSPECIMENS
BIOSPECIMENS IN CANCER RESEARCH
BIOSPECIMENS - THE LEGACY PLAN
DECADES OLD SPECIMENS MAY BE TODAY’S RESEARCH TREASURES

3. BIOREPOSITORIES FOR LONG-TERM PRESERVATION AND FUTURE ANALYSIS
BIOSPECIMEN SAMPLE COLLECTION AND PREPARATION
CONSIDERATIONS FOR LONG-TERM SAMPLE STORAGE
POLICES FOR SAMPLE STORAGE
INFORMATION MANAGEMENT AND AUDIT TRAILS
BIOREPOSITORY CAPABILITIES
COLD CHAIN LOGISTICS
CONCLUSION

4. OVERVIEW OF THE PRIVACY RULE’S IMPACT ON REPOSITORIES AND DATABASES
ALTERATION OF THE AUTHORIZATION REQUIREMENT BY AN IRB OR PRIVACY BOARD
OTHER PRIVACY RULE REQUIREMENTS
MINIMUM NECESSARY STANDARD
RIGHT TO AN ACCOUNTING OF DISCLOSURES

5. MAJOR PROSPECTS FOR BIOREPOSITORIES IN THE FUTURE
THE KEY IMPACT OF BIOREPOSITORIES IN ITS APPLICATIONS

BIGGEST CHALLENGES AND OPPORTUNITIES IN BIOREPOSITORIES
BIGGEST CHALLENGES
BIGGEST OPPORTUNITIES
PRESENT CHALLENGES OF BIOBANKING: BIOETHICAL AND PROPERTY ISSUES

ADDED VALUE OF BIOBANKS FOR HEALTH: AN EVOLUTIONARY PERSPECTIVE
FUTURE CHALLENGES
CONCLUSIONS

B. A REVIEW ON BIO “BANKS”
RELEVANCE OF BIOBANKS IN SCIENTIFIC RESEARCH

BIOBANKS TYPES
POPULATION-BASED BIOBANKS
PUBLIC BIOBANKING
AROUND THE WORLD AND WITHIN THE USA
THE PUBLIC POPULATION PROJECT IN GENOMICS (P3G)

THE NEED OF MODERN BIOBANKS
BENEFITS

BIOBANKING COSTS
PROCEDURE OF ESTIMATING THE BIOBANKING COST
FACTORS INFLUENCING BIOBANKS PRICES
COST STRUCTURE
INSTITUTIONAL
GOVERNMENT
ACCESS
MARKET FORCES

DIFFERENT TYPES OF ACTORS INVOLVED IN BIOBANKS

BIOREPOSITORY SERVICES

1. BIOBANKING BENEFITS
CONCLUSION

2. CURRENT ROLE OF BIOBANKING IN MEDICAL ENVIRONMENT
A CASE FOR OUTSOURCING
A BIOMATERIAL STORAGE PROVIDER
COLD-CHAIN MANAGEMENT, TRACKING AND MONITORING
BIOREPOSITORY COSTS
SAMPLE INTEGRITY
THE FUTURE OF BIOREPOSITORIES
THE VALUE OF BIOLOGICAL SPECIMENS AND MEDICAL INFORMATION FOR MEDICAL RESEARCH

3. THE ROLE OF BIOSPECIMENS FOR DISCOVERY OF A TARGETED CANCER THERAPY

4. A REVIEW ON BIOMARKERS IN BIOBANKING
ROLE OF BIO-BANKS IN BIOMARKER-RELATED RESEARCH
CONSENSUS GUIDELINES FOR CSF BIOBANKING AND BLOOD BIOBANKING FOR CNS BIOMARKER STUDIES
COLLECTION PROCESS
STORAGE PROCESS
SAMPLES ADMINISTRATION PROCESS
MAINTENANCE OF PATIENT INFORMATION DATABASE
CONCLUSION

BRAIN/TISSUE/BIOBANKS (BTB) BANKS FOR BIOMARKERS IN NEUROLOGICAL DISORDERS

BIOMARKERS IN CLINICAL USE – THERAPEUTIC AREA – GLOBAL

5. A REVIEW ON GLOBAL BIOBANKING
RESEARCH BIOBANKING IN THE GLOBAL CONTEXT: PROS AND CONS

5.1. NORTH AMERICA
BIOBANKING IN THE USA
STEM CELL BANKS
LIST OF STUDIES USING BLOOD SPECIMENS / DNA RESEARCH BANKS IN THE US
TISSUE BANK/BLOOD BANK RESOURCES
REGULATORY ASPECTS
ETHICS DISCUSSION

BIOBANKING IN CANADA
REGULATORY ASPECTS
ETHICS DISCUSSION
BLOOD SPECIMENS AND DNA RESEARCH BANKS
TISSUE COLLECTION BANKS

BIOBANKING IN LUXEMBOURG
GUIDELINES

BIOREPOSITORIES / BIOBANKING - NORTH AMERICAN MARKET BRIEFING
END-USERS

5.2. EUROPE
INTRODUCTION

IMPACT OF POPULATION SURVEYS AND BIOBANKING
HEALTH POTENTIAL
SOCIO-ECONOMIC POTENTIAL
INDUSTRY POTENTIAL
LEGAL, POLITICAL AND SOCIAL POTENTIAL

EUROPEAN STRENGTHS
INTERNATIONAL CONTEXT
KEY CHALLENGES OF EUROPEAN BIOBANKING
FUNDING

RECOMMENDATIONS FOR EUROPEAN BIOBANKING AND POPULATION SURVEYING
GOAL
SCOPE
LEGAL AND ETHICAL FRAMEWORK FOR COLLABORATIVE BIOBANKING ACROSS EUROPE

EXTENT OF BIOBANKING IN EUROPE
CHALLENGES IN IMPROVING BIOBANKING
TECHNOLOGICAL CHALLENGES
DATA COMPARABILITY AND STANDARDIZATION (IT & BIOINFORMATICS)
LEGAL, REGULATORY AND ETHICAL REQUIREMENTS
PRIVACY PROTECTION AND SECURITY ISSUES
ROLE OF ETHICS REVIEW BOARDS
NETWORKING AMONG “SMALLER” BIOBANKS
CONCLUSION

REGULATORY ASPECTS
EUROPEAN BIOBANKING INDUSTRY COMPARISON: PRESENT AND THE NEXT 10 YEARS

BIOBANKING IN SWEDEN
REGULATORY ASPECTS
ETHICS DISCUSSION
BIOBANKS IN SWEDEN

BIOBANKING IN NORWAY
REGULATORY ASPECTS
BIOBANKS IN NORWAY

BIOBANKING IN DENMARK
REGULATORY ASPECTS
BIOBANKS IN DENMARK

BIOBANKING IN FINLAND
REGULATORY ASPECTS
BIOBANKS IN FINLAND

BIOBANKING IN ICELAND
REGULATORY ASPECTS
ETHICS DISCUSSION
BIOBANKS IN ICELAND

BIOBANKING IN SPAIN
STRENGTHS
WEAKNESSES
THE SPANISH SCIENTIFIC ENVIRONMENT
REGULATORY ASPECTS

BIOBANKING IN THE UNITED KINGDOM
CORD BLOOD BANKING
REGULATORY ASPECTS
ETHICS DISCUSSION
BIOBANKS IN THE UNITED KINGDOM

BIOBANKING IN HUNGARY
BIOBANKING COMPANIES IN HUNGARY

BIOBANKS IN ROMANIA
REGULATORY ASPECTS

BIOBANKING IN AUSTRIA
REGULATORY ASPECTS
ETHICS DISCUSSION

BIOBANKING IN BELGIUM
REGULATORY ASPECTS

BIOBANKING IN GERMANY
REGULATORY ASPECTS
ETHICS DISCUSSION

BIOBANKING IN THE NETHERLANDS
PUBLIC BIOBANKS FOR RESEARCH PURPOSES IN THE NETHERLANDS
COMMERCIAL BIOBANKS
REGULATORY ASPECTS

BIOBANKING IN ITALY
REGULATORY ASPECTS
BIOBANKS IN ITALY

BIOBANKING IN FRANCE
REGULATORY ASPECTS

BIOBANKING IN REST OF EUROPE
BALTIC COUNTRIES
REGULATORY ASPECTS
ETHICS DISCUSSION
BIOBANKS IN BALTIC COUNTRIES
BIOBANKS IN SOUTHERN EUROPE

BIOBANKING IN IRELAND
GUIDELINES

BIOREPOSITORIES / BIOBANKING - EUROPEAN MARKET BRIEFING
END-USERS

5.3. ASIA-PACIFIC
BIOBANKING IN JAPAN
BIOBANKS IN JAPAN

BIOBANKING IN SINGAPORE
ACTIVITIES
RESEARCH & DEVELOPMENT
RESOURCES & INFRASTRUCTURE
TRAINING AND EDUCATION
BIOBANKS IN SINGAPORE

BIOBANKING IN CHINA

BIOBANKING IN INDIA
ETHICAL DISCUSSION
BIOBANKS IN INDIA
BIOBANKING GUIDELINES

BIOBANKING IN SOUTH KOREA
BIOBANKS IN SOUTH KOREA

BIOBANKING IN TAIWAN

BIOBANKING IN THE REST OF ASIA-PACIFIC
REGULATORY ASPECTS
ETHICAL DISCUSSION
BIOBANKS IN THE REST OF ASIA-PACIFIC

BIOREPOSITORIES / BIOBANKING - ASIA-PACIFIC MARKET BRIEFING
END-USERS

6. INTERNATIONAL REGULATORY INITIATIVES

II. MARKET ANALYSIS
A. BIOREPOSITORIES / BIOBANKING:END-USERS -SEGMENTATION
BIOREPOSITORIES - GLOBAL

BIOREPOSITORIES - BY - COUNTRY ANALYSIS
NORTH AMERICA
EUROPE
ASIA-PACIFIC
REST OF WORLD

BIOREPOSITORIES - END-USERS - GLOBAL
BIOREPOSITORIES - END-USERS - GEOGRAPHIC REGION
PHARMACEUTICALS
NORTH AMERICA
EUROPE
ASIA-PACIFIC
REST OF WORLD

BIOTECHNOLOGY
NORTH AMERICA
EUROPE
ASIA-PACIFIC
REST OF WORLD

PERSONAL CARE
NORTH AMERICA
EUROPE
ASIA-PACIFIC
REST OF WORLD

FOOD AND BEVERAGE
NORTH AMERICA
EUROPE
ASIA-PACIFIC
REST OF WORLD

PETROCHEMICALS
NORTH AMERICA
EUROPE
ASIA-PACIFIC
REST OF WORLD

OTHER END-USERS
NORTH AMERICA
EUROPE
ASIA-PACIFIC
REST OF WORLD

B. GROWTH RATE ANALYSIS
GLOBAL BIOREPOSITORIES MARKET GROWTH RATES

BIOREPOSITORIES MARKET - END-USERS
GLOBAL BIOREPOSITORIES END-USERS - GROWTH RATES
GLOBAL PHARMACEUTICALS MARKET GROWTH RATES
GLOBAL BIOTECHNOLOGY MARKET GROWTH RATES
GLOBAL PERSONAL CARE MARKET GROWTH RATES
GLOBAL FOOD AND BEVERAGE MARKET GROWTH RATES
GLOBAL PETROCHEMICALS MARKET GROWTH RATES

C. INVESTMENT FOCUS
III. INDUSTRY OVERVIEW
A. BIOREPOSITORIES AND GLOBAL NETWORKING
BIOBANKING TRENDS, CHALLENGES AND OPPORTUNITIES
BIOBANKS: TRANSNATIONAL, EUROPEAN AND GLOBAL NETWORKS
WIPING OUT CHRONIC DISEASE MAY ADD 10% TO SOUTH ASIA GDP

B. HUMAN GENETIC BIOBANKS: POLITICS OF TRUST AND SCIENTIFIC ADVANCEMENT

C. KEY POINTS IN BIOBANKING INCLUDES: DEVELOPMENT, COLLECTION, INFORMATICS, REGULATORY, LEGAL AND ETHICAL ISSUES

D. WORKSHOP ON COMMON STANDARDS FOR BIOBANKS AND BIOSPECIMEN RESEARCH

E. STEM CELLS BIOBANKING – A RAPID GROWING MARKET

STEM CELLS - MARKET TRENDS
STEM CELL TREATMENTS GIVE NEW EXPECTATION
DONOR STEM CELL RESEARCH MAY REPAIR HEART DAMAGE
ANTI-AGING INDUSTRY GOES FOR STEM CELL THERAPY
STEM CELL TREATMENT TO CURE DIABETES
HOTTEST DEVELOPMENTS IN STEM CELLS TREATMENTS
STEM CELL PROGRESS BEING HIT BY TRADITIONALIST

WORLD MARROW DONOR ASSOCIATION (WMDA)

ASIA AT WMDA

F. BIOBANKING IN PEDIATRICS: THE HUMAN NON-SUBJECTS APPROACH
INTRODUCTION
FUTURE PERSPECTIVE

G. INDUSTRY ACTIVITIES
MERGERS/ACQUISITIONS/AGREEMENTS/PATENTS GRANTS/JOINT VENTURES/ETC……
ARGENTA AND BIOFOCUS EXTEND DRUG DISCOVERY COLLABORATION WITH GENENTECH
THERMO FISHER SCIENTIFIC LAUNCHES HYPERSEP™ SLE SAMPLE PREPARATION OPTION
SEWARD STOMACHER® 400 CIRCULATOR FOR E.COLI 0157 FOOD SAFETY STUDY
PORVAIR SCIENCES – SPECIALISTS IN CUSTOM MANUFACTURE OF MICROPLATES
THERMO FISHER SCIENTIFIC LAUNCHES HISTOSTAR EMBEDDING SYSTEM
COTI-2 – A MILESTONE FOR CRITICAL OUTCOME TECHNOLOGIES
STRATOPHASE’S OPTICAL BIODETECTOR TO DETECT RICIN AND ANTHRAX TOXIN IN TESTS
IMPACT OF PRODUCT RESISTANCE ON PRIMARY FREEZE DRYING
INTEGRA ENLIGHTENS USE OF VIAFLO 96* AND VIAFLO VOYAGER**
GENEVAC LAUNCHES HT SERIES II SOLVENT EVAPORATORS
ENCAP DRUG DELIVERY LAUNCHES COLON-SCREEN
BOEHRINGER INGELHEIM SIGNS LICENSING AGREEMENT FOR PROBIOGEN’S GLYMAXX® TECHNOLOGY
APCETH OBTAINS MANUFACTURER’S LICENSE FOR SOMATIC CELL THERAPY
CHART INDUSTRIES ACQUIRES THE GOFA GROUP
INC RESEARCH AND DEBIOPHARM GROUP ™ ENTER INTO STRATEGIC PARTNERSHIP
ORASURE TECHNOLOGIES WILL ACQUIRE DNA GENOTEK
BROOKS AUTOMATION ACQUIRES NEXUS BIOSYSTEMS
BROOKS AUTOMATION SUPPLIES SMARRTSTORE DNA STORAGE SYSTEM TO LIFELINES
CEPHALON’S FENTORA AND ACTIQ OBTAIN FDA APPROVAL FOR RISK EVALUATION AND MITIGATION STRATEGY
NEW TOOLS FOR CELL CRYOPRESERVATION BY BIOCISION
LABVANTAGE SELECTED FOR PROVIDING WORLD-CLASS SERVICES, BY LEADING FOOD SAFETY AND QUALITY ORGANIZATION
TECAN AND TECHNICAL COMMUNITIES VENTURED WITH THE GOVERNMENT
GERMANY SELECTS QIAGEN AS COMPANY WITH MOST INNOVATIVE MANAGEMENT STRATEGY
DNA GENOTEK’S ORAGENE®•DNA COLLECTION KIT SELECTED BY EXISTENCE GENETICS FOR PREDICTIVE MEDICINE SERVICE
BECKMAN COULTER DEMONSTRATES LS 13 320 LASER DIFFRACTION ANALYZER AND CELEBRATES FOOD AT IFT CONFERENCE
BECKMAN COULTER’S CESI 8000 HIGH-PERFORMANCE SEPARATION-ESI MODULE WITH OPTIMS TECHNOLOGY—A BLESSING FOR MASS SPECTROMETRY
SAIC-FREDERICK AND BIOMATRICA COLLABORATE TO IMPROVE MOLECULAR ANALYSIS IN CANCER RESEARCH
ASTERAND AND 5AM SOLUTIONS SIGN A PREFERRED PARTNERSHIP AGREEMENT
BIOSTORAGE TECHNOLOGIES INAUGURATES NEW BIOREPOSITORY IN INDIANAPOLIS
BIOSTORAGE TECHNOLOGIES OPENS A NEW BIOREPOSITORY FACILITY
INTERNATIONAL COLLABORATION ON ADHD AND SUBSTANCE ABUSE (ICASA) CHOOSES DNA GENOTEK’S ORAGENE•DNA
SANYO AND INSPEC GET CONTRACT FOR PV SYSTEM AND SMART ENERGY SYSTEM INSTALLATION AT THE OREGON SUSTAINABILITY CENTER IN PORTLAND
THERMO FISHER SCIENTIFIC SIGNS PACT WITH CINVEN TO ACQUIRE PHADIA
“STEM CELLS—THE DENTAL CONNECTION”: CONTINUING EDUCATION PROGRAM FOR ORAL SURGEONS AND DENTISTS
DNA GENOTEK LAUNCHES OMNIGENE™•DISCOVER FOR INFECTIOUS DISEASE SAMPLING
THERMO FISHER SCIENTIFIC PURCHASES STERILIN
THERMO FISHER SCIENTIFIC ACHIEVES COMPLETE TAKE OVER OF DIONEX
THERMO FISHER SCIENTIFIC FULFILSTENDER OFFER TO ACQUIRE DIONEX CORPORATION
BIOSTORAGE TECHNOLOGIES, INC. NOW WITH GLOBAL BIOBANKING COMMUNITY
TRANS-HIT BIOMARKERS PARTICIPATES IN CQDM-FUNDED MCGILL UNIVERSITY PROJECT
LABVANTAGE PROVIDES COMPREHENSIVE DATA SOLUTIONS TO LABS AND IS TOPMOST INTEGRATED SOLUTION PROVIDER
75 MILLION HPV TESTS AND STILL GOING STRONG, QIAGEN REACHES MILESTONE AND ANNOUNCES STRATEGY UPDATE FOR QIAENSEMBLE PROGRAM
SERACARE ANNOUNCES RENEWAL OF CONTRACT FROM NHLBI
THERMO FISHER SCIENTIFIC ANNOUNCES PLAN TO DEVELOP A MANUFACTURING UNIT IN SUZHOU, CHINA
CUSTOMER-FRIENDLY COMPLEX ANTIBODIES
PREVENTION FOR CERVICAL CANCER @RWANDA BY MERCK AND QIAGEN
ACQUISITION OF SOFTWARE POINT BY LABVANTAGE
PROMETIC SIGNS AGREEMENT WITH CELGENE CORPORATION FOR GLOBAL RIGHTS TO COMMERCIAL APPLICATION OF PROTEIN TECHNOLOGIES
CHART INDUSTRIES TAKES OVER CLEVER FELLOWS INNOVATION CONSORTIUM
THERMO FISHER SCIENTIFIC SELLS LANCASTER LABORATORIES AND ATHENA DIAGNOSTICS
STORE­A­TOOTH COLLABORATES WITH CORDON DE VIDA TO PRESERVE STEM CELLS FROM TEETH
BIOTECH ENTREPRENEURS LAUNCH ABCODIA AND CALL FOR COLLABORATIVE PARTNERS
CALIPER IS AN ACCEPTED PARTNER FOR HISTORXIN BIOMARKERS IN TISSUE
SPECIAL HUMAN CELLS DERIVED FROM STEM CELLS RESTORE MOVEMENT IN RATS WITH SPINAL CORD INJURY
ASTROCYTES DERIVED FROM HUMAN STEM CELLS IMPROVE THE LOCOMOTOR FUNCTIONS OF RATS WITH SPINAL CORD INJURY
CORD BLOOD AMERICA PURCHASE OF CORD BLOOD STEM CELLS STORED BY REPRODUCTIVE GENERATIVE INSTITUTE AN ILLINOIS FIRM
LIFESPAN OF BONE MARROW STEM CELLS PREDICTED THROUGH COMPUTER MODEL, SOLVES THE REGENERATIVE PROBLEMS
RECENT STUDY REVEAL A COMBINATION OF CELLASTIM AND OPTIFERRIN IS IDEAL FOR STEM CELL EXPANSION WHICH REPLACES NEED OF BLOOD PRODUCTS
CALIPER AND COVARIS COLLABORATED TO SIMPLIFY NEXT GENERATION SEQUENCING
GILEAD SCIENCES SIGNS AGREEMENT TO ACQUIRE CALISTOGA PHARMACEUTICALS
BIOKRYO GMBH BECOMES AN ASSOCIATE OF ESBB
SINGLE BLASTOMERE TECHNOLOGY SECURES PATENT TO GENERATE EMBRYONIC STEM CELLS ENSURING EMBRYO SAFETY
MESENCHYMAL STEM CELLS TO IMPROVE THE DAMAGED CELLS AFTER HEART ATTACK
STEMCELLS, INC. COMPLETES SECOND TRIAL OF HUCNS-SC(R) NEURAL STEM CELLS, A POTENTIAL TREATMENT FOR MYELINATION DISORDER
AMNIOTIC FLUID COLLECTED DURING THIRD TRIMESTER IS A RELIABLE SOURCE OF STEM CELLS FOR REGENERATIVE MEDICINE AND STEM CELL BANKING
CORD BLOOD AMERICA, INC. ANNOUNCES PURCHASE OF MINORITY INTEREST IN VIDAPLUS EXPECTED TO GAIN REVENUE AND POPULARITY IN EUROPE
INDUCED PLURIPOTENT STEM CELLS ARE SAFER AND CANCEROUS GROWTH MAY BE AVOIDED
MICRORNAS ENHANCES THE GENERATION OF INDUCED PLURIPOTENT STEM CELLS (IPS), THROUGH REPROGRAMMING SKIN STEM CELLS
BIOSTORAGE TECHNOLOGIES HOSTS GLOBAL SAMPLE MANAGEMENT BENCHMARKING SYMPOSIUM IN CONJUNCTION WITH BIOREPOSITORIES ASIA CONFERENCE
TECAN AND SWORD DETECTED HIGH PERFORMANCE IMMUNOASSAY TECHNOLOGY
BECKMAN COULTER’S IMPRESSIVE DISPLAYS AT LABAUTOMATION2011 TO HIGHLIGHT GENOMIC AND CELLULAR ANALYSIS WORKFLOW SOLUTIONS
NUGENAND CALIPER COLLABORATED FOR CLEARINGNEXT-GEN TECHNOLOGY BOTTLENECKS
HAMILTON PUTS IN AN INTEGRATED AUTOMATED COMPOUND STORAGE AND SCREENING SYSTEM
A HYDROSPEED™ PLATE WASHER BY TECAN
ROLE OF STEM CELLS IN REPAIRING DAMAGED HEART OF CHILDREN
THE FRAUNHOFER INSTITUTE IS FOCUSED TO STUDY THE CELL THERAPEUTIC PROCESSES IN ORDER TO OFFER SUITABLE SOLUTIONS
MIRNA THERAPEUTICS, INC. PUBLISH NEW DATA ON MIR-34 IN INHIBITING THE GROWTH OF CANCER CELLS
BIOCELLS, INC., TO STORE DENTAL PULP STEM CELLS WHICH AIDS IN STIMULATING NEURAL CELLS AND A SOURCE OF REGENERATIVE MEDICINE
NEOSTEM, INC.'S RECOMMENDED FOR THE FINANCIAL AWARD OF $1,700,000 DEVELOPING VERY SMALL EMBRYONIC-LIKE STEM CELLS WHICH IS A POTENTIAL CURE FOR OSTEOPOROSIS FROM DEPARTMENT OF DEFENSE PEER REVIEWED MEDICAL RESEARCH PROGRAM
BIOHEART REPORTS THE USE OF ADIPOSE DERIVED STEM CELLS IN CURING CRITICAL LIMB ISCHEMIA
POSITION OF DNA IN STEM CELL TRANSPLANT SUCCESS & FUNDING
THE CHEAPEST STEM CELL TRANSPLANT FROM INDIA
CHART INDUSTRIES ACQUIRED SEQUAL TECHNOLOGIES
THERMO FISHER SCIENTIFIC ACQUIRES LOMB SCIENTIFIC
THE BEST BIOINFORMATICS CORPORATION IS OCIMUM BIOSOLUTIONS IN 2010
CALIPER LIFE SCIENCES IS DONE WITH CRI ACQUISITION
GILEAD SCIENCES SIGNS AGREEMENT TO ACQUIRE ARRESTO BIOSCIENCES
IBBL AND WAFERGEN ENTER COLLABORATION IN RESEARCH AND EQUIPMENT
THERMO FISHER SCIENTIFIC GETS APPROVAL FOR ACQUISITION OF DIONEX
CALIPER LIFE SCIENCES OBTAINS CAMBRIDGE R&I
DECODE GENETICS ANNOUNCES DISCOVERY OF GENETIC MARKERS THAT IMPROVE THE POWER OF PSA TESTING
HUMAN STEM CELLS CALLED PARTHENOGENETIC CELLS, WHICH ARE DEVELOPED BY UNFERTILIZED HUMAN EGGS-ETHICAL CONSIDERATIONS AND MEDICAL ADVANTAGES
ADVANCED CELL TECHNOLOGY AND THE ROSLIN INSTITUTE ANNOUNCE AGREEMENT FOR STORAGE AND DISTRIBUTION OF EMBRYONIC STEM CELLS USING ACT'S BLASTOMERE TECHNOLOGY
STEM CELL TECHNOLOGY - A BREAKTHROUGH IN GROWING FUNCTIONAL INTESTINE TISSUE
ASM SOFTWARE IS RESTRUCTURED BY HAMILTON ACTIVE SAMPLE MANAGEMENT STORAGE TECHNOLOGIES
TECAN AND COVARIS COLLABORATED FOR FREEDOM EVO®
RURO LAUNCHES EZCOLONY 2011
ADVANCED CELL TECHNOLOGY CLEARED BY FDA FOR THE FIRST CLINICAL TRIAL ON USING RETINAL STEM CELLS FOR CURING STARGARDT’S MACULAR DYSTROPHY
EHSI: STEM CELLS COULD HELP HEART ATTACK VICTIMS
STEMCYTE, INC. RECEIVED TWO AWARDS TOTALING TO $488,950 FOR ADVANCED THERAPEUTIC APPLICATIONS OF UMBILICAL CORD BLOOD STEM CELLS FROM THE QUALIFYING THERAPEUTIC DISCOVERY PROJECT (QTDP)
SHRINK NANOTECHNOLOGIES REVEALS VIDEOS OF STEMDISC450 PROTOTYPE, A DEVICE FOR GROWING HUMAN EMBRYONIC STEM CELLS
X-BODY BIOSCIENCES AWARDED GRANT FOR THERAPEUTIC DISCOVERY PROJECT TARGETING METASTATIC TUMOR STEM CELLS
VIVAKOR SIGNS GLOBAL LICENSING AGREEMENT WITH MIT HOLDING FOR VIVATHERMIC VIALS
STEM CELLS REPAIR DAMAGED SPINAL CORD TISSUE IN RATS
ROCHE´S CELLAVISTA SYSTEM ENHANCES THE STUDY OF SELF RENEWAL OF EMBRYONIC STEM CELLS
BIOCISION INITIATES CRYOPREP SYSTEM FOR COMPETENT AND EXTREMELY REPRODUCIBLE CELL PRESERVATION
BIOMATRICA NEW-FANGLED STABILIZATION TECHNOLOGY USED FOR BLOOD DNA PRESERVATION
BIOMATRICA LAUNCHES DNAGARD® BLOOD AND DNASTABLE® BLOOD
CEPHALON SIGNS AGREEMENT TO FUND CHEMGENEX
NEXUS BIOSYSTEMS PURCHASES REMP SAMPLE MANAGEMENT BUSINESS FROM TECAN GROUP
CEPHALON ACQUIRES MEPHA
TECAN IS FIRST CHOICE FOR QUALITY AND RELIABILITY
LARGE CAPACITY ULT FREEZER THE LATEST FROM NEW BRUNSWICK SCIENTIFIC
GERON ENTERS INTO A LICENSE AGREEMENT FOR PRODUCTION OF CHONDOCYTES FROM IPS
SHAKERS, INCUBATORS, FREEZERS GET NEW DATA LOGGING SOFTWARE
RURO INTRODUCES SCIENCY ELN 2.0 STANDARD – NEW VERSION OF SOFTWARE
CHART ACQUIRES CRYOTECH INTERNATIONAL
GUIDED ADULT STEM CELLS CAN EFFECTIVELY REPAIR HEARTS
SERACARE LIFE SCIENCES INTRODUCES NEW HIV SEROCONVERSION PANELS
ARUP LABORATORIES AND DECODE GENETIC IN PARTNERSHIP TO OFFER DECODE PROSTATECANCER™ TEST
THERMO FISHER SCIENTIFIC TAKES OVER FERMENTAS
NEXUS BIOSYSTEMS SIGNS AGREEMENT TO ACQUIRE TECAN’S REMP SAMPLE MANAGEMENT BUSINESS
ERAGEN BIOSCIENCES GETS FDA CLEARANCE FOR MULTICODE-RTX HSV 1 & 2 KIT WITH SEQWRIGHT’S BACKING
OCIMUM BIOSOLUTIONS COMMENCED WITH LIMS, BIOTRACKER™ LITE
OCIMUM BIOSOLUTIONS OFFERS BIOIT CONSULTING FOR R&D IN LIFE SCIENCES
NEW CULTURE DISH OVERCOMES THE LIMITATIONS IN HUMAN EMBRYONIC STEM CELL RESEARCH
THERMO FISHER SCIENTIFIC SIGNS CONTRACT TO ACQUIRE FERMENTAS
RURO INTRODUCES FREEZEERPRO MULTISITE
CALIPER LIFE SCIENCES SELLS PRODUCT LINES, RAPIDTRACE® AND TURBOVAP®, TO BIOTAGE
PREVIEW OF CRYOXTRACT’S NOVEL AUTOMATED FROZEN SAMPLE ALIQUOTTER AT ISBER 2010
TECAN ASSESS RADIATION EXPOSURE WITH ARIZONA STATE UNIVERSITY
INDIVUMED BECOMES THE FIRST ISO-9001:2008 CERTIFIED BIOBANK IN THE WORLD
NEW-FANGLED CLEAN ROOM MONITORING SOLUTION BY VERITEQ
THERMO FISHER SCIENTIFIC ACQUIRES ‘EASY-NLC’ PROVIDER PROXEON
HUNT BIOSCIENCES SIGNS COLLABORATION AGREEMENT WITH TISSUE SOLUTIONS
STEM CELL THERAPY A MAJOR ROLE FOR ACUTE LUNG DAMAGE IN MICE
VAISALA ACQUIRES VERITEQ INSTRUMENTS
THERMO FISHER SCIENTIFIC AND LILLY MAKE FIVE-YEAR AGREEMENT FOR CLINICAL TRIAL MATERIALS RELATIONSHIP
ACCESS TO TISSUES FOR ONCOLOGY R & D
STRATEGIC ALLIANCE FOR SAMPLE STORAGE AND CONVERSION SERVICES
BIOCISION COLLABORATED WITH SERVA ELECTROPHORESIS
UNSWERVING WASHING NEXTERION® PLATES BY TECANHYDROFLEX™
CARDIOVASCULAR GENETIC TESTING AT BERKELEY HEARTLAB MADE EASY WITH GENTEGRA™ DNA FROM GENVAULT
CALIPER ANNULS LAWSUIT AGAINST SHIMADZU
TRANS-HIT LAUNCHES “QUICK OPPORTUNITIES”
THERMO FISHER SCIENTIFIC TAKES OVER FINNZYMES WHOLLY
THERMO FISHER SCIENTIFIC ACQUIRES AHURA SCIENTIFIC
STARLIMS SHAREHOLDERS APPROVE OF ACQUISITION BY ABBOTT
VERITEQ’S 10-STEP GUIDE ON “HOW TO RESPOND TO (AND AVOID) FDA 483S”
BIOCISION LANDS NEW DISTRIBUTION PARTNER WITH BIOPHORETICS DEAL
AUTOMATION BOOSTS SAMPLE PREPARATION FOR NEXT-GENERATION SEQUENCING
U.S. NATIONAL CANCER INSTITUTE CHOOSES INDIVUMED TO STUDY THE INTEGRITY OF BIOSPECIMEN SAMPLING PROCEDURES
CALIPER LAUNCHES SCICLONE G3
THERMO FISHER SCIENTIFIC SIGNS FINAL AGREEMENT TO ACQUIRE AHURA SCIENTIFIC
ANNOUNCING THE LAUNCH OF SANYO PROFESSIONAL AIR WASHER PLUSTM FOR COMMERCIAL ENVIRONMENTS, SUPPRESSING VOCS, BACTERIA, AIRBORNE GERMS, MOLD, ODOR AND ALLERGENS
CALIPER AGREES TO LICENSE MICROFLUIDICS IP TO BECTON DICKINSON
GENTEGRA™ RNA INTRODUCED BY GENVAULT CORPORATION
OCIMUM BIOSOLUTIONS STANDS IN 4TH PLACE AS THE FASTEST GROWING TECHNOLOGY COMPANY
CRYOXTRACT COMPLETES SUCCESSFUL TESTING OF INNOVATIVE ROBOTIC FROZEN ALIQUOTTER
ACQUISITION OF STARLIMS ENHANCES ABBOTT'S DIAGNOSTICS PORTFOLIO AND EXPERTISE IN IM SYSTEMS; ALSO EXPANDS STARLIMS' PRESENCE ACROSS LABORATORY MARKETS
SUPPLY AGREEMENT WITH LIFE TECHNOLOGIES ANNOUNCED BY GENVAULT
NEXUS BIOSYSTEMS ACQUIRES AURORA BIOTECHNOLOGIES
RTS LIFE SCIENCE AND INNOVATIVE VISION TECHNOLOGY LAUNCHES TUBE AUDITOR
CALIPER INTRODUCES LIVING IMAGE® 4.0 SOFTWARE
CHART ANNOUNCES CAIRE’S ACQUISITION OF COVIDIEN’S OXYGEN THERAPY BUSINESS
SANYO PROPOSES SPEEDY IN SITU H2O2 CELL CULTURE WITH CO2 INCUBATOR STERILIZATION METHOD
TISSUE SOLUTIONS WINS “NEXXUS’ 2009 MOST PROMISING YOUNG LIFE SCIENCE AWARD”
CALIPER PARTNERS WITH SRU BIOSYSTEMS TO INTRODUCE LABEL-FREE, CELL-BASED GPSR ASSAY TECHNOLOGIES
BIOCISION SIGNS DISTRIBUTION DEAL WITH CAPITAL BIOSCIENCES
THERMO FISHER SCIENTIFIC LAUNCHES COPEPTIN ASSAY IN EUROPE
THE GREAT EXCHANGE– LIMS SWAPS FROM OCIMUM BIOSOLUTIONS
ORAGENE®•DNA USED TO DISCOVER GENETIC LINK TO PODOCONIOSIS
THERMO FISHER SCIENTIFIC ACQUIRES B.R.A.H.M.S.
CALIPER INTRODUCES XENOLIGHT REDIJECT D-LUCIFERIN ULTRA
BECKMAN COULTER EXPANDS DRUGS OF ABUSE TEST MENU WITH BUPRENORPHINE ASSAY
THERMO FISHER SCIENTIFIC SIGNS AGREEMENT TO ACQUIRE B.R.A.H.M.S. AG
RESOURCEFUL DRUG EXPLORED WITH TECAN’S FREEDOM EVO® 75
ROBOTICS AND PROTEOMICS: A PROMISING PARTNERSHIP FOR BIOMARKER DISCOVERY
BIOCISION INITIATED COOLCELL FOR ALCOHOL-FREE CELL FREEZING
454 LIFE SCIENCES, ELI LILLY AND SEQWRIGHT TEAM UP TO USE GENOMIC TECHNOLOGIES FOR PSYCHIATRIC DISORDERS
SEQWRIGHT COLLABORATES WITH ROCHE FOR RESEARCH ON GENETIC CAUSES FOR DILATED CARDIOMYOPATHY
CEPHALON GAINS CONTROLLING INTEREST IN ARANA THERAPEUTICS
INDIVUMED AND VENTANA ORGANIZE CANCER RESEARCH SYMPOSIUM
THERMO FISHER SCIENTIFIC ENTERS INTO AGREEMENT TO ACQUIRE BIOLAB
CENTRALIZED AND STANDARDIZED SOFTWARE SOLUTION - THE LATEST FROM GENVAULT CORPORATION
A SPECIAL TB DAY WITH AWARENESS CAMPAIGN
NATIONAL CANCER INSTITUTE’S (NCI) PROPOSAL FOR U.S.’S FIRST NATIONAL BIO-BANK
BECKMAN COULTER LAUNCHES GALLIOS™ FLOW CYTOMETRY SYSTEM
STARLIMS FEATURES IN $4M PROJECT SELECTED BY WORLD LEADER IN BIOTECH
TECAN’S NANOQUANT™ PLATE GETS UNDER THE SKIN OF STEM CELLS
DECODE RECEIVES CLINICAL LABORATORY LICENSE FROM THE STATE OF CALIFORNIA
ILLUMINA SNP GENOTYPING SERVICES BY GENE LOGIC
IMPRESSIVE PREVIEW OF CRYOXTRACT’S NOVEL ROBOTIC TECHNOLOGY AT LABAUTOMATION 2009
DATAWORKS DEVELOPMENT INTRODUCES FREEZERWORKS UL 4.0
DECODE LAUNCHES DECODEME CARDIO™ AND DECODEME CANCER™
BIOCISION’S ADVANCED TEMPERATURE MANAGEMENT IN MICROFUGE TUBES
TECAN NOW WITH DISPOSABLE TIPS FOR 96-MULTICHANNEL ARM™
A CERTIFIED SERVICE PROVIDER FOR NUGEN OVATION® SYSTEMS IS OCIMUM BIOSOLUTIONS
RTS LIFE SCIENCE TO EXHIBIT FREE SAMPLE MANAGEMENT AUTOMATION AUDIT AT LABAUTOMATION 2009

H. MARKET TRENDS
ENHANCING EFFICIENCY AND SECURITY OF BIOREPOSITORIES
IMPROVING EFFICIENCY OF BIOBANKING BY AUTOMATION
INVENTORY MANAGEMENT OF SAMPLES IN BIOBANKS
SAMPLE QUANTITATION WITH MICROVOLUME TOOLS-THERMO SCIENTIFIC NANODROP 8000
SIGNIFICANCE OF BIOBANKS IN BIOMARKER DISCOVERY PROGRAMS
NEED FOR STANDARDIZED PROCEDURES IN BIOBANKS
ADVANCED IT DEVICES REJUVENATE BIOBANKING
PRESERVATION OF BIOLOGICAL SPECIMEN INTEGRITY
BIOMARKER DEVELOPMENT – KEYSTONE OF DIAGNOSIS AND TREATMENT
STANDARDIZATION AND AUTOMATION OF BIOBANKS - NEED OF THE HOUR

H. BIOREPOSITORIES / BIOBANKING - INDUSTRY LEADERS
BECKMAN COULTER
CALIPER LIFE SCIENCES, INC.
CEPHALON, INC.
CHART INDUSTRIES, INC.
GILEAD SCIENCES, INC.
MYLAN, INC.
RAND CORPORATION
SERACARE LIFE SCIENCES
TECAN
AASTROM BIOSCIENCES, INC.
BIOHEART, INC.
CORD BLOOD REGISTRY
CRYOLIFE, INC.
OSIRIS THERAPEUTICS, INC.
SIGMA-ALDRICH, CO.
STEM CELL INNOVATIONS, INC.
THERMO FISHER SCIENTIFIC, INC.
VIACORD
RENEURON GROUP PLC
CRYOCORD SDN.BHD.
BARBER NICHOLS
CHARTER MEDICAL, LTD.
CRYOMAGNETICS, INC.
CUSTOM BIOGENIC SYSTEMS
ORIGEN BIOMEDICAL, INC.
CRYOGENETICS AS
LINDE GAS CRYOSERVICES B.V.
CRYOLOGIC PTY. LTD.
GENESEARCH

I. BIOREPOSITORIES / BIOBANKING – A LOOK AHEAD..!!

J. BIOREPOSITORIES / BIOBANKING - KEY COMPANY PROFILES
NORTH AMERICA
EUROPE
ASIA-PACIFIC

IV. INDUSTRY COMPANY DATABASE
KEY BIOBANKS INVOLVED IN ANIMALS AND PLANTS
BIOBANKS ASSOCIATED WITH BBMRI IN EUROPE

V. APPENDIX
A. RESEARCH FOCUS
B. ABOUT AXIS RESEARCH MIND
C. DISCLAIMER
D. FEEDBACK

LIST OF TABLES/CHARTS
I. REPORT FOCUS
1. MAJOR BIOREPOSITORIES GROWTH RATES FOR STORAGE OF MATERIAL - BY TYPE IN COMBINATIONS - 2010-%
2. POTENTIAL NEEDS AND USES FOR BIOSPECIMENS BY CONSTITUENCY
3. GLOBAL BIOBANKS BY RESEARCH MODELS - 2010
4. CHARACTERISTICS OF TISSUE SAMPLE COLLECTION BY TYPE OF CANCER
5. GLOBAL BIOMARKERS MARKET FORECASTS IN CLINICAL USE BY THERAPEUTIC AREA - (2009-2015, IN USD$ MILLION)
6. GLOBAL BIOMARKERS MARKET FORECASTS IN CLINICAL USE BY THERAPEUTIC AREA - % OF MARKET VALUE - (2009 - 2012 - 2015)

BIOREPOSITORIES / BIOBANKING - NORTH AMERICAN MARKET BRIEFING
END-USERS
7. BIOREPOSITORIES - END-USERS - PHARMACEUTICALS, BIOTECHNOLOGY, PERSONAL CARE, FOOD AND BEVERAGE, PETROCHEMICALS AND OTHERS FOR NORTH AMERICA - (2009-2015, IN USD$ MILLION)
8. BIOREPOSITORIES - END-USERS - PHARMACEUTICALS, BIOTECHNOLOGY, PERSONAL CARE, FOOD AND BEVERAGE, PETROCHEMICALS AND OTHERS - % OF NORTH AMERICAN MARKET VALUE - (2009 - 2012 - 2015)

BIOREPOSITORIES / BIOBANKING - EUROPEAN MARKET BRIEFING
9. INVENTORY ON EXISTING POPULATION BIOBANKS IN EUROPE - MARCH 2011
10. BIOSPECIMENS COLLECTED BY VARIOUS BIOBANKS FROM THEIR ESTABLISHMENT IN EUROPE

END-USERS
11. BIOREPOSITORIES - END-USERS - PHARMACEUTICALS, BIOTECHNOLOGY, PERSONAL CARE, FOOD AND BEVERAGE, PETROCHEMICALS AND OTHERS FOR EUROPE - (2009-2015, IN USD$ MILLION)
12. BIOREPOSITORIES - END-USERS - PHARMACEUTICALS, BIOTECHNOLOGY, PERSONAL CARE, FOOD AND BEVERAGE, PETROCHEMICALS AND OTHERS - % OF EUROPEAN MARKET VALUE - (2009 - 2012 - 2015)

BIOREPOSITORIES / BIOBANKING - ASIA-PACIFIC MARKET BRIEFING
END-USERS
13. BIOREPOSITORIES - END-USERS - PHARMACEUTICALS, BIOTECHNOLOGY, PERSONAL CARE, FOOD AND BEVERAGE, PETROCHEMICALS AND OTHERS FOR ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
14. BIOREPOSITORIES - END-USERS - PHARMACEUTICALS, BIOTECHNOLOGY, PERSONAL CARE, FOOD AND BEVERAGE, PETROCHEMICALS AND OTHERS - % OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)

II. MARKET ANALYSIS
A. BIOREPOSITORIES / BIOBANKING:END-USERS -SEGMENTATION
15. GLOBAL BIOREPOSITORIES- SEGMENTATION BY END-USERS

B. BIOREPOSITORIES - GLOBAL
16. BIOREPOSITORIES-GLOBAL CURRENT TRENDS, ESTIMATES & FORECASTS -(2009-2015, IN USD$ MILLION)
17. BIOREPOSITORIES - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC ANDREST OF WORLD - (2009-2015, IN USD$ MILLION)
18. BIOREPOSITORIES - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)

B1. BIOREPOSITORIES - BY - COUNTRY ANALYSIS
19. BIOREPOSITORIES - USA, CANADA AND MEXICO - (2009-2015, IN USD$ MILLION)
20. BIOREPOSITORIES - % OF USA, CANADA AND MEXICO MARKET VALUE - (2009 - 2012 - 2015)
21. BIOREPOSITORIES - BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, ITALY,SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
22. BIOREPOSITORIES - % OF BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, ITALY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
23. BIOREPOSITORIES - AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
24. BIOREPOSITORIES - % OF AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE -(2009 - 2012 - 2015)
25. BIOREPOSITORIES - ARGENTINA, BRAZIL, COLUMBIA, MIDDLE EAST,SOUTH AFRICA AND REST OF REST OF WORLD - (2009-2015, IN USD$ MILLION)
26. BIOREPOSITORIES - % OF ARGENTINA, BRAZIL, COLUMBIA, MIDDLE EAST,SOUTH AFRICA AND REST OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)

I. BIOREPOSITORIES - END-USERS - GLOBAL
27. BIOREPOSITORIES - END-USERS - PHARMACEUTICALS, BIOTECHNOLOGY, PERSONAL CARE, FOOD AND BEVERAGE, PETROCHEMICALSAND OTHERS FOR GLOBAL CURRENT TRENDS, ESTIMATES & FORECASTS - (2009-2015, IN USD$ MILLION)
28. BIOREPOSITORIES - END-USERS - PHARMACEUTICALS, BIOTECHNOLOGY, PERSONAL CARE, FOOD AND BEVERAGE, PETROCHEMICALS AND OTHERS - % OF GLOBAL MARKET VALUE - (2009 - 2012 - 2015)

BIOREPOSITORIES - END-USERS - GEOGRAPHIC REGION
I.A. PHARMACEUTICALS
29. BIOREPOSITORIES - END-USERS - PHARMACEUTICALS - BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
30. BIOREPOSITORIES - END-USERS - PHARMACEUTICALS - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)
31. BIOREPOSITORIES - END-USERS - PHARMACEUTICALS FOR USA, CANADA AND MEXICO - (2009-2015, IN USD$ MILLION)
32. BIOREPOSITORIES - END-USERS - PHARMACEUTICALS - % OF USA, CANADA AND MEXICO MARKET VALUE - (2009 - 2012 - 2015)
33. BIOREPOSITORIES - END-USERS - PHARMACEUTICALS FOR BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, ITALY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
34. BIOREPOSITORIES - END-USERS - PHARMACEUTICALS - % OF BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, ITALY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
35. BIOREPOSITORIES - END-USERS - PHARMACEUTICALS FOR AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
36. BIOREPOSITORIES - END-USERS - PHARMACEUTICALS - % OF AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
37. BIOREPOSITORIES - END-USERS - PHARMACEUTICALS FOR ARGENTINA, BRAZIL, COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD - (2009-2015, IN USD$ MILLION)
38. BIOREPOSITORIES - END-USERS - PHARMACEUTICALS - % OF ARGENTINA, BRAZIL, COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)

I.B. BIOTECHNOLOGY
39. BIOREPOSITORIES - END-USERS - BIOTECHNOLOGY - BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
40. BIOREPOSITORIES - END-USERS - BIOTECHNOLOGY - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)
41. BIOREPOSITORIES - END-USERS - BIOTECHNOLOGY FOR USA, CANADA AND MEXICO - (2009-2015, IN USD$ MILLION)
42. BIOREPOSITORIES - END-USERS - BIOTECHNOLOGY - % OF USA, CANADA AND MEXICO MARKET VALUE - (2009